Women who stopped antidepressant treatment during pregnancy and resumed in the following weeks had a rebound effect of increased prescription of benzodiazepines and anxiolytics.
Children exposed to maternal depression have an increased risk for developmental vulnerability at school entry, with stronger associations for exposure to maternal depression before age 1 year and between ages 4 and 5 years.
Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.
The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.
Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression.
A team of investigators assessed the impact of anxiety and mood disorders on treatment with anti-tumor necrosis factor agents in individuals with inflammatory bowel disease.
The case of an older woman who underwent treatment with accelerated intermittent theta burst stimulation for major depressive disorder is reported.
Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Therapists trained in IPSRT examined patients’ interpersonal patterns and social rhythms, as well as how they affected mood symptoms and interpersonal functioning.
Mothers who have children with MS have a higher prevalence of physical conditions, as well as a higher prevalence of mood and anxiety disorders.